Hold-rated reports

559 tickers rated Hold
Ranks this page's recent reports by score.
Sempra
SRE·Utilities
B ★★★Hold
Current$94.85
Target$105.00
Return+10.7%
Jul 10, 2026

Sempra offers arguably the highest-visibility growth in the entire utility sector via Texas data center electrification, but a tight valuation and structural California wildfire risks cap immediate upside potential.

Score
75
Targa Resources Corp.
TRGP·Energy
B ★★★Hold
Current$277.86
Target$289.00
Return+4.0%
Jul 10, 2026

Targa possesses an unstoppable, oligopolistic stranglehold over Permian-to-export NGL infrastructure driving massive cash flow compounding, but its astronomically stretched valuation leaves absolutely zero room for operational missteps or macro commodity shocks.

Score
79
Keysight Technologies, Inc.
KEYS·Technology
B ★★★Hold
Current$322.17
Target$385.00
Return+19.5%
Jul 10, 2026

Keysight boasts unparalleled dominance in AI data center and 6G testing with record-breaking financial execution, but its premium valuation leaves little room for error if hyperscaler infrastructure investments decelerate.

Score
80
Performance Food Group Company
PFGC·Consumer Staples
B ★★★Hold
Current$111.53
Target$130.00
Return+16.6%
Jul 10, 2026

Performance Food Group is flawlessly consolidating the foodservice industry and generating massive free cash flow, but aggressive insider selling, peak valuation multiples, and high debt levels suggest the current stock price requires time to digest its recent gains.

Score
75
McCormick & Company, Incorporated
MKC·Consumer Staples
B ★★★Hold
Current$51.57
Target$60.00
Return+16.3%
Jul 10, 2026

McCormick is an elite, moat-protected compounder trading at a historical discount, but near-term upside is capped by the massive execution risks and debt load accompanying its transformational $44.8 billion Unilever acquisition.

Score
81
AutoZone, Inc.
AZO·Consumer Discretionary
B ★★★Hold
Current$3,070.17
Target$3,500.00
Return+14.0%
Jul 9, 2026

AutoZone is an elite, counter-cyclical compounder expanding rapidly into the lucrative commercial market, but short-term margin compression and looming industry consolidation threats cap near-term multiple expansion.

Score
80
Pfizer Inc.
PFE·Healthcare
B ★★★Hold
Current$24.05
Target$29.00
Return+20.6%
Jul 9, 2026

High dividend yield and severe undervaluation provide an immense margin of safety, but looming patent cliffs and binary pipeline execution risks severely cap near-term upside.

Score
76
Axon Enterprise, Inc.
AXON·Industrials
B ★★★Hold
Current$599.80
Target$691.60
Return+15.3%
Jul 9, 2026

Axon's AI-driven transition from hardware to a sticky, high-margin software ecosystem ensures massive recurring revenue growth, but an astronomical 65x forward P/E leaves the stock violently exposed to any execution stumbles or municipal budget cuts.

Score
82
Sun Life Financial Inc.
SLF·Financials
B ★★★Hold
Current$79.39
Target$82.00
Return+3.3%
Jul 9, 2026

Sun Life Financial is an elite, capital-light wealth compounder leveraging massive Asian demographic growth, but its premium valuation and persistent margin drag in U.S. group benefits limit near-term upside.

Score
78
IDEXX Laboratories, Inc.
IDXX·Healthcare
B ★★★Hold
Current$557.80
Target$709.00
Return+27.1%
Jul 9, 2026

IDEXX boasts an impenetrable, high-margin diagnostic monopoly riding the secular wave of pet humanization, but its current 38x multiple requires absolute perfection in an environment of declining U.S. veterinary foot traffic.

Score
82
SharkNinja, Inc.
SN·Consumer Discretionary
B ★★★Hold
Current$151.10
Target$175.00
Return+15.8%
Jul 9, 2026

SharkNinja combines relentless consumer-centric innovation and category disruption with 20%+ CAGRs, though near-term tariff risks and premium multiples require careful entry management.

Score
80
Best Buy Co., Inc.
BBY·Consumer Discretionary
B ★★★Hold
Current$78.72
Target$87.00
Return+10.5%
Jul 9, 2026

While Best Buy's unmatched 4.9% yield and massive cash generation provide a bulletproof floor, its absolute dependence on a cyclical, macro-delayed consumer electronics recovery caps its near-term upside velocity.

Score
81
Amgen Inc.
AMGN·Healthcare
B ★★★Hold
Current$367.67
Target$400.00
Return+8.8%
Jul 9, 2026

Amgen offsets inevitable legacy biosimilar erosion with fierce double-digit growth from Repatha, Tezspire, and rare disease assets, while holding a massive valuation wildcard in the obesity space with MariTide.

Score
76
Chevron Corporation
CVX·Energy
B ★★★Hold
Current$176.63
Target$216.48
Return+22.6%
Jul 9, 2026

Chevron offers a highly durable 4.09% yield and unique growth via its Hess acquisition and Microsoft AI deal, but climbing debt and massive insider liquidation warrant a cautious hold.

Score
79
Wynn Resorts, Limited
WYNN·Consumer Discretionary
B ★★★Hold
Current$95.91
Target$135.00
Return+40.8%
Jul 8, 2026

Wynn Resorts offers a premium portfolio with strong mass-market momentum in Macau and an upcoming UAE monopoly, though significant leverage and heavy near-term capex warrant a Hold position.

Score
79
Marriott International, Inc.
MAR·Consumer Discretionary
B ★★★Hold
Current$379.75
Target$410.00
Return+8.0%
Jul 8, 2026

Marriott International is an unstoppable asset-light compounder fueled by the 283 million-member Bonvoy ecosystem, but its fully stretched 39x P/E multiple leaves little room for macroeconomic error, warranting a Hold.

Score
81
Warner Bros. Discovery, Inc.
WBD·Communication Services
B ★★★Hold
Current$26.48
Target$31.00
Return+17.1%
Jul 8, 2026

An asymmetric special situation anchored by a $31.00 all-cash M&A bid, though heavily haunted by the existential threat of European antitrust interference blocking the deal.

Score
76
Live Nation Entertainment, Inc.
LYV·Communication Services
B ★★★Hold
Current$184.71
Target$200.00
Return+8.3%
Jul 8, 2026

Live Nation's unstoppable vertically integrated flywheel and record cash generation are temporarily offset by severe antitrust headwinds and elevated valuation multiples.

Score
76
e.l.f. Beauty, Inc.
ELF·Consumer Staples
B ★★★Hold
Current$76.42
Target$96.00
Return+25.6%
Jul 8, 2026

e.l.f. Beauty is transforming into a diversified, high-margin prestige beauty platform via rhode and Naturium, but intense tariff exposure and sudden unit volume sensitivity in its core mass-market brand demand a cautious approach until supply chain diversification is complete.

Score
75